Also, treating the cells with the aptamer drastically hampers the αvβ3-mediated cell attachment to vitronectin in vitro and strongly reduced the tumor uptake of the IntegriSense αvβ3-targeting agent, as assessed by in vivo imaging analyses of TNBC xenografts. Here, VTN is linked to neoplasm.